Nference AI technology enables knowledge synthesis from unstructured text and structured biomedical databases. It synthesizes exponentially growing biomedical knowledge to solve urgent healthcare problems. The company uses state-of-the-art neural networks for real-time, automated extraction of insights by triangulating unstructured and structured information from the biomedical literature as well as from large scale molecular and real-world datasets. The platform enables a diverse set of applications ranging from R&D to commercial strategy and operations in the life sciences ecosystem. In the last 15 years, the world has seen a massive digitization of healthcare information driven by the exponential increase and availability of scientific literature, molecular data and real world evidence. Advances in next-generation sequencing have significantly reduced the cost of sequencing and this has enabled large-scale initiatives like the UK Biobank where 500K patients have been sequenced and their de-identified clinico-genomic data is now available to scientists worldwide.
Total Funding: $74 M
Funding Stage: Series B
Business Stage: Scaling Up
Market: B2B
Company Size: 251 to 500
Founded: 2015
